Bioscience

Five new hospitals order ValiMed MVS by CDEX to protect patients

April 14, 2010

By Flinn Foundation

[Source: Market Watch] – CDEX Inc.  announces it has received five orders for ValiMed(TM) Medication Validation Systems (MVS) from new hospital clients in states including Illinois, Pennsylvania, Florida, and Colorado. Studies worldwide continue to show high numbers of mistakes in the compounding of high-risk medications resulting in substantial harm to patients and economic loss to hospitals. ValiMed MVS is used to validate the compounding of high-risk liquid medications in a pharmacy setting and also as a verification and trending program to identify and reduce the diversion of return narcotics in hospitals and other healthcare facilities.

For more information: Five New Hospitals Order ValiMed(TM) MVS by CDEX to Protect Patients